MISSISSAUGA, ON, April 7, 2026 /CNW/ - Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha(R) (evolocumab injection) for eligible ...
Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha® (evolocumab injection) for ...
VESALIUS-CV data supported evolocumab reducing MACE in high-risk primary prevention diabetes over 4.8 years, reinforcing the ...
Investor's Business Daily on MSN
How Merck's new cholesterol buster will 'move the needle' 'by removing the needle'
Merck's experimental cholesterol buster easily outperformed a triplet of medications, the Dow Jones component said Monday.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit of Earlier Initiation of Repatha ...
April 2 (Reuters) - U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices in line with those paid in other developed nations in ...
NEW ORLEANS — Patients with diabetes who have not been diagnosed with atherosclerotic cardiovascular disease would benefit by taking the PCSK9 inhibitor evolocumab to lower their LDL cholesterol to ...
NEW ORLEANS -- This weekend, catheter-based therapies have potentially practice-changing trial results expected at the American College of Cardiology (ACC) annual conference. Kicking off the opening ...
The federal direct-to-consumer website TrumpRx.gov currently lists 54 brand-name medications accessible through manufacturer-run cash discount programs. That number is expected to grow, as the White ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results